Objectives: Several Leishmania strains with episomal expression of green fluorescent protein (GFP) require constant drug pressure for its continuous expression and hence limit its use in ex vivo or in vivo systems. The aim of this study was to alleviate this problem by stably integrating the GFP gene into the parasite genome, so as to use these transfectants for ex vivo and in vivo drug screening.
Introduction
Current in vitro antileishmanial screening methodologies, such as microscopic counting, radioactive nucleotides, colorimetric assays and reporter-gene-based assays, have several drawbacks necessitating the need for rapid, convenient and reliable screening assays. 1 Green fluorescent protein (GFP) from Aequorea victoria is now emerging as an exciting tool for antimicrobial drug screening for several pathogens and parasitic organisms. GFP-based assays offer several advantages over other non-reporter-or reporter-gene-based assays, including greater simplicity, easier kinetic monitoring, low cost and enhanced biosafety. 2 Expression of GFP in several parasite species has been achieved and applied for drug testing studies. 1 GFP expression in Leishmania was first achieved by Ha et al. 3 Since then its expression by episomal vector has been carried out in several species of Leishmania, 4,5 wherein the fluorescence intensity in parasites decreased with time in the absence of geneticin sulphate (antibiotic G418), thereby necessitating its regular addition. 6 To alleviate these shortcomings, the integration of the GFP gene downstream of the 18S rRNA gene promoter was done at the ribosomal locus within the genome of the parasite, which represents a valuable tool for drug screening in macrophages or in animals when a long period of growth without drug selection is required. To our knowledge this is the first report of stable integration of GFP into Leishmania donovani clinical isolates (2001 and 2039) and its infectivity to hamsters.
Materials and methods
The L. donovani clinical isolates 2001 [sodium stibogluconate (SAG)-susceptible] and 2039 (SAG-resistant), obtained from patients, and WHO reference strain Dd8 were grown in medium M199 as described previously.
4,7 J774.1 macrophages were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% heat-inactivated fetal bovine serum at 378C in 5% CO 2 in a humidified atmosphere. 7 For stable transfection, constructs (vector pRib1.2aNEOaGFP for integration of GFP gene downstream of promoter of 18S rRNA of L. donovani-a gift from Dr Papadopoulou, Infectious Diseases Research Center, CHUL Research Center, Laval University, Quebec, Canada) were linearized with restriction enzyme BstXI (Fermentas). The digestion product was precipitated and dissolved in the required amount of MilliQ. About 300 mL of a cell suspension of each isolate (1Â10 8 promastigotes/mL) was put into a 2 mm electroporation cuvette (Molecular Bio-Products, USA) and 20 mg of linearized vector was mixed with the cells. Cells were electroporated using a Genepulser instrument (Bio-Rad, USA) at 0.45 kV and 500 mF under minimum resistance conditions. Selection of transfectants was initiated 24 h after electroporation at 10 mg/mL G418 and gradually increased in a stepwise manner up to 750 mg/mL. After initial drug selection growth was optimized (400 mg/mL) and G418 was removed from the culture. The stable transfectants were designated as LdGFP int Dd8, LdGFP int 2001 and LdGFP int 2039, and were further cultured without G418.
Genomic DNA was isolated from GFP-promastigotes using a Nucleospin DNA isolation kit (Machery-Nagel) following the manufacturer's protocol. Homologous recombination of the GFP gene at the 18S ribosomal locus of L. donovani promastigotes was confirmed by PCR and western blotting. 8 GFP expression in live promastigotes and intracellular amastigotes was visualized using a fluorescence microscope (Nikon, USA). 4, 9 Flow cytometric (FACS) analysis of promastigotes and infected macrophages was performed using a FACSCalibur flow cytometer (BD Biosciences, USA) equipped with a 15 mV and 488 nm air-cooled argon ion laser with excitation at 488 nm and emission at 515 nm. Live promastigotes as well as uninfected and infected macrophages (1Â10 5 cells/mL) were suspended in 500 mL of PBS, analysed by FACS 5 and data were processed using CellQuest software. The percentage of GFP-parasiteinfected macrophages and their mean fluorescence intensities (MFIs) were measured with respect to control macrophages.
Antileishmanial drugs miltefosine (Asta Medica), pentamidine, paromomycin and SAG (all from Sigma) were dissolved in MilliQ or DMSO and stored at 2708C until used. Drug solutions were prepared as 10 mM or 1 mg/mL stocks in the appropriate medium before the assay.
For the in vitro drug screening assay, GFP-transfected promastigotes (1Â10 6 cells/mL/well) were put into 48-well culture plates and exposed to different concentrations of drugs/test samples in triplicate. Untreated controls were kept for each assay. After 72 h of treatment, MFIs of treated and untreated cell samples were quantified by FACS. Parasite inhibition was measured in terms of the decrease in intensity of green fluorescence in treated cultures and calculated by comparing the intensity of fluorescence in treated and untreated cultures according to the following formula:
Percentage inhibition
fluorescence of treated samples fluorescence of untreated samples Â 100
IC 50 values (drug concentrations that resulted in 50% inhibition of parasite growth) were determined by Microsoft (MS) xlfit sigmoidal regression analysis. For ex vivo drug screening, J774.1 macrophage cells, plated at a cell density of 5Â10 5 cells/mL in a 24-well tissue culture plate, were infected with stationary phase GFP-promastigotes at a ratio of 10:1 ( parasites/macrophage) and incubated at 378C in 5% CO 2 for 24 h. Cells were washed with medium to remove non-phagocytosed parasites and exposed to different dilutions of standard drugs/test samples for 48 h and were analysed by FACS.
Results were expressed as means+SD. Statistical differences were examined by the unpaired t-test. The level of significance was determined at P,0.05.
The infectivity of the transfectants was checked in golden hamsters (Mesocricetus auratus) weighing 40 -45 g (with the prior approval of the institutional animal ethics committee; IAEC) with LdGFP int Dd8 promastigotes. The assessment of parasitic burden in a splenic dab smear was done on days 45 and 60 post-infection by fluorescence microscopy.
Results and discussion L. donovani was transfected with the linearized integration cassette and the GFP gene was integrated at the chromosomal level downstream of the DNA Pol I-driven promoter of the 18S rRNA gene, which was confirmed by PCR (Figure 1a) . The amplification of the GFP gene from the genomic DNA of GFP-transfectants indicates that this gene is integrated in the genome of the parasites. The expression of GFP in GFP-transfectants was validated by western blotting. Polyclonal rabbit antiserum to GFP recognized the 27 kDa protein in the GFP-transfectant whole cell lysates (Figure 1b) . No such protein was detectable in the wild-type promastigotes. Integration at the ribosomal locus has previously been reported to result in constitutive, enhanced and stable expression of luciferase in Leishmania major and L. donovani, 6 and of GFP in Leishmania mexicana.
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After initial selection of transfectants from 10 to 750 mg/mL, the addition of G418 was stopped and the growth of transfectants was observed over a period of 12 months. Highly motile and typical elongated transfected promastigotes revealed bright and constitutive green fluorescence distributed throughout the cytoplasm and in flagella, as observed under a fluorescence microscope (Figure 1c) . It can be inferred that integration of GFP in the Leishmania genome does not affect the viability and morphology of promastigotes. FACS analysis of both GFP-transfectants and wild-type parasites revealed distinct separation, as the MFI values of stable transfectants (240 -250 units) were $150-200 times higher than those of the wild-type parasites (2-3 units). The stability of GFP expression was monitored over a period of 12 months post-electroporation and it was observed that there was no decrease in MFI at all during this period in the absence of G418 (Figure 1d ). Simultaneous microscopic examinations also confirmed the presence of fluorescent parasites and no significant reduction in the percentage of GFP-expressing cells was noticed (Figure 1e ). These observations strongly confirmed the stable and enhanced nature of GFP expression in L. donovani transfectants.
GFP-promastigotes were found to be infective to the macrophages, as macrophages were fully packed with the fluorescent amastigotes as observed at 48 h post-infection by epifluorescent microscopy [$65% -70% of macrophages acquired infection having 3 -25 amastigotes/cell and were clearly visible in infected macrophages for .7 days (Figure 1f ) ]. FACS facilitated the conclusive separation of the uninfected macrophage population (MFI of 3-5 units) from the infected population (MFI of 46+6 units) based on differences in fluorescence levels between the two populations, which were 15-25-fold higher in the infected population compared with the uninfected population (Figure 1g) .
The efficacy of standard antileishmanials was evaluated against GFP-promastigotes as well as intracellular GFP-amastigotes. The IC 50 s of the standard drugs using GFP-transfectants are summarized in Table 1 . GFP-promastigotes were found to be highly susceptible to miltefosine, amphotericin B and pentamidine, in a concentration-dependent manner. SAG was inactive against promastigotes (IC 50 .800 mg/mL), correlating well with earlier reports. (Table 1) . Treatment with miltefosine, amphotericin B and pentamidine also resulted in a decrease in fluorescence. Differences in the IC 50 values obtained may be influenced by the nature of cell lines, Leishmania species and the batch of drug used.
J774.1 macrophages infected with both
The stable transfectants, namely LdGFP int Dd8, were also found to be infective to hamsters with intense fluorescence, as observed by fluorescence microscopic examination of splenic dab smears of hamsters infected for 45 and 60 days (Figure 1h ).
In conclusion, we have developed improved L. donovani transfectants that can stably express the reporter green fluorescent gene without any drug pressure and that have been Mean values of three independent experiments are given.
a Other assays include those described by other published results. 11 -23 
